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Abstract 
 
Background: Malaria is still the primary cause of pediatric deaths. The efficient management of pediatric malaria 
requires its rapid and accurate diagnosis. To fulfill this requirement, rapid diagnostic tests have been developed, but 
their evaluation before commercialization is never exhaustive. The aim of this study was to evaluate the performance of 
a rapid diagnostic test (SD Bioline Malaria Antigen P.f/Pan) to diagnose malaria in children.  
Materials and Methods: Testing was conducted on children aged between 6 months and 15 years who were examined 
at the “Centre Mère Enfant (CME) of the “Chantal Biya” Foundation (FCB). as a result of fever. Enrollment took place 
from April to October 2014. All children presenting with fever were sampled (3ml of blood). These blood samples 
were tested for malaria using microscopy on a thick blood smear and by a rapid diagnostic test (RDT) SD Bioline 
Malariae Antigen P.f/Pan.  
Results: A total of 249 children were enrolled in this study. Malaria presence as determined by microscopy and by 
RDT was 30.9% and 58.2% respectively. The sensitivity, specificity, positive and negative predictive values compared 
to microscopy were: 75; 48.8; 39, and 81.6%. With these performances, the malaria SD Bioline rapid test presents 
lower values compared to WHO recommendations for rapid tests (sensitivity > 95%) in children.  
Conclusion: SD Bioline Malaria Antigen P.f/Pan test should only be used in peripheral health structures that lack 
resources, and should be aided by clinical diagnosis. 
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Introduction 
 
 Malaria is a life-threatening blood disease caused by Plasmodium spp. and is transmitted to humans by the 
Anopheles mosquito. Once bitten, parasites multiply in the host's liver before infecting and destroying red blood cells. 
These are the exclusive vectors of these parasites with about 400 species, nearly 60 transmitting the disease (Brysker et 
al., 1988; Pick, 1994). The disease is particularly prevalent in tropical areas (Pick, 1994). The disease can be controlled 
and treated if diagnosed early. Unfortunately, this is not possible in some areas of the world lacking medical facilities, 
where malaria outbreaks can occur. At the moment, no malaria vaccine is available. 
 According to WHO estimates, 300 to 500 million cases of malaria occur each year worldwide, causing 1.5 
to 2.7 million deaths. It is a scourge in the warm tropical regions of Africa, South and Central America and Asia where 
the disease is quasi-permanently present. In 2009, the disease was endemic in 109 countries. Those countries also 
happen to be among the poorest in the world- "poverty belt" (Gentillini, 1995). Forty-five (45) of these 109 countries 
are located in sub-Saharan Africa alone accounting for almost 90% of the total incidence of malaria (WHO, 2009a).  
In Cameroon, in 2010, malaria was still responsible for 40.1% of overall hospital morbidity and 40% mortality in 
children under 5. Two million cases are recorded in health facilities each year and malaria care and management cost 
represents 40% of household expenditure on health and resulted in a 1.3% loss in growth rate in 2007, according to the 
Ministry of Public Health (MSP). Here, over 90% of malaria cases are due to P. falciparum (MSP, 2010). The strategy 
for the management of malaria is modeled on WHO recommendations. Initially, diagnosis was based on clinical 
symptoms, including fever, even when laboratory confirmation was not done (Lalloo et al., 1992; Zurovac et al., 2006).  
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But this strategy showed its limitations following the emergence of vector resistance to insecticides and Plasmodium 
resistance to anti-malarials. The consequences were chromosomal mutations especially to chloroquine (Ononi et al., 
1982) in most countries affected by P. falciparum including Cameroon. 
 In the 2006 and 2010 guidelines, WHO reviewed its strategy and recommended prompt parasitological 
confirmation of all clinical cases before starting treatment except where this is not possible. This requirement for 
laboratory confirmation is a problem because of the difficulty in making available quality microscopy (confirmatory 
test) and experienced personnel (Moody, 2002).  
 This binding requirement for quality microscopy limits access to quality care and management of malaria 
(Msellem et al, 2009). In Cameroon, more than half of the reported cases are not confirmed in the laboratory and a 
large population trend towards self-medication has been noted (MSP, 2010). Furthermore, studies by Durrheim et al. 
(1997), have shown that the results of microscopic examinations differ significantly from one laboratory to another and 
from one technician to another. Hence, the introduction of rapid diagnostic tests (RDTs) for malaria in the early 90s by 
WHO was suggested as a credible alternative to conventional microscopy (Lubell et al., 2007; Wonsrichanalai et al., 
2007).  
 To date, several malaria RDTs are available, detecting one or more antigens of the histidine-rich protein 2 
(HRP-2) from Plasmodium falciparum and the parasite-specific lactate dehydrogenase (pLDH) or Plasmodium aldolase 
from the parasite glycolytic pathway found in all species (Moody, 2002). Many studies have been published on the 
worldwide assessment of RDT performance with very variable results according to manufacturers, contexts, regions 
and target populations. The disparity of published results for these tests says a lot about the complexity to make the 
choice of a RDT for malaria among the very many existing products by different firms (22 in use in Cameroon) (Ali et 
al., 2016). Furthermore, the performance of these tests is influenced by the genetic variability of the parasites (Baker et 
al., 2005).  
 Given that countries are increasingly willing to spend money in scaling up diagnosis tests for malaria, it is 
necessary to guide them in the choice of rapid diagnostic tests that meet international standards of quality and give 
information on the selection criteria recommended for the purchase of rapid diagnostic tests for malaria. 
The objectives of this work were: to determine the performance of RDT SD Malaria Antigen Pf / Pan (SD- RDT) in the 
laboratory diagnosis of malaria in Yaoundé on children aged 6 months to 15 years by comparison to the thick blood 
smear test namely: sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).  
 
Materials and Methods 
Design, Setting, and Population Studied 
 
 This study was carried out at the “Centre Mère Enfant (CME) of the “Chantal Biya” Foundation (FCB) in 
Yaoundé from April 2014 to October 2014. This is a reference health facility for children, located in the political 
capital of Cameroon (Yaoundé). It is visited by patients living in Yaoundé as well as patients referred from surrounding 
health facilities and even surrounding Regions. 
Included in this study, were children aged 6 months to 15 years consulting in the pediatric ward of the CME-FCB and 
had a fever of 38°C or above (or had symptoms characteristic of malaria). A questionnaire was administered to the 
mother of the child and data such as age, sex, Long Lasting Insecticide-treated bed nets (LLINs) usage and HIV status 
were collected. 
Blood was collected from each of these children and used to detect Plasmodium parasites (thick blood smear) or 
Plasmodium antigens (SD-RDT). Microscopy was done by two independent technicians and the results were compared. 
Discordant results were repeated by a third microscopist. RDT testing was done according to the manufacturer’s 
instructions (Standard Diagnostics Inc. 156-68, Hagal-dong Giheung-guYongin-sikyonggi-do, Korea 446/930). The 
SD-RDT is a rapid, qualitative and differential test for the detection of histidine-rich protein II (HRP-II) antigen 
of Plasmodium falciparum and common Plasmodium lactate dehydrogenase (pLDH). Its claimed sensitivity is 99.7% 
(P.f), 95.5% (non-P.f) and specificity of 99.5%.  
 
Ethics Consideration 
 
 The study received the approval of the National Ethical Committee (N° 2013/03/086/L/ CNERSH/SP) and 
the authorization of the Ministry of Public Health (631-15.13). Parents or guardians gave informed and written proxy 
consent before enrollment. 
 
Statistical Analysis 
 
 Data were recorded in Microsoft Excel 2010 and exported to IBM-SPSS Version 21 for statistical analysis.  
Quantitative variables were reported as number (%). Since continuous variables deviated significantly from normality, 
the median with the interquartile range (IQR) was used.  Associations were quantified with odds ratios (OR) with 95% 
confidence interval (CI). The Cochran-Armitage test was used to assess the trend with ordinal variables.  
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The Receiver Operating Characteristic (ROC) curve was used to assess the predictive performances of SD-RDT. P-
values less than 5% were considered statistically significant. 
 
Results 
 
A total of 249 children aged from 6 months to 15 years were recruited, with a median age of 2 years 
[Interquartile range: 11 months-4 years]. They were 134 (53.8%) boys and 115 (46.2%) girls, thus a sex ratio (B/G) of 
1.16 in favor of boys.  The overall descriptive characteristic of the study population is presented in Table 1.  
 
Table 1: Descriptive characteristic of the study population: Microscopy results according to sex, age, bed net usage and 
HIV status 
 Microscopy Negative 
N (%) 
173(69.5) 
Microscopy Positive 
N (%) 
76(30.5) 
Total 
249 
OR(95%CI) P 
Sex      
Boys 102(76.1) 32(23.9) 134 (53.8) 1  
Girls 71(61.7) 44(38.3) 115(46.2) 1.97(1.14-
3.41) 
0.015 
Age (years)*       
<=2 107(79.3) 28(20.7) 135(54.2) 1  
2-5 44(63.8) 25(36.2) 69(27.7) 2.17(1.14-
4.13) 
0.018 
>=5 22(48.9) 23(51.1) 45(18.1) 4.00(1.95-
8.19) 
0.000 
Bed net usage      
No 57(68.7) 26(31.3) 83(33.3) 1  
Yes 116(69.9) 50(30.1) 166(66.7) 0.94(0.53-
1.67) 
0.85 
HIV      
Negative 142(66.7) 71(33.3) 213(85.5) 3.1(1.15-8.31) 0.025 
Positive 31(86.1) 5(13.9) 36(14.5) 1  
* p-Cochran-Armitage test of trend = 0.00006 
 
 The prevalence of malaria infection confirmed by microscopy was 30.5% (76/249). The prevalence 
determined using the SD-RDT was 58.2% (145/249). 
Table 1 also shows that the prevalence of malaria was significantly higher in girls (38.3%) compared to boys (23.9%); 
girls were nearly twice as likely to be positive than boys (OR = 1.97(1.14-3.41), P = 0.015). The prevalence of malaria 
decreased significantly (p < 0.0001) as age increased.  
Children older than 5 years and those aged 2-5 years were respectively four times (OR = 4(1.95-8.19), p = 
0.001)) and two times (OR = 2.17(1.14-4.13), p = 0.018)) more likely to be positive than children less than 2 years of 
age. This has been demonstrated in other studies to be due to the circulation of anti-plasmodial antibodies acquired 
from mothers during pregnancy (Bruce-Chwatt, 1952, Sehgal et al., 1989). The usage of bed nets was 66.67%.  
However, there was no clear prevalence as a function of bed net usage (p = 0.85). The peak-biting activity of 
Plasmodium-transmitting mosquitoes is known to be between midnight and 05.00 hours, and the majority of 
mosquitoes bite humans indoors and the rest indoors (www.malariasite.com/anopheles-mosquito/ downloaded on the 
15 december, 2016). Changes in the biting pattern of the malaria vectors between biting earlier or later in the night and 
biting outdoors (Expert Committee on Malaria, 2000; Maxwell et al., 1998) could justify why no difference was found 
between LLINS usage and malaria prevalence. We found that bed net usage vary with the age as shown in Table 2. 
 
Table 2: Bed net usage according to age 
                        Bet net usage  
Age (years, p-Cochran-
Armitage test of trend=0.000) 
No n (%) Yes n (%) Total OR(95%CI) P 
<=2 34(25.2) 101(74.8) 135(54.2) 4.46(2.19-9.08) 0.00 
2-5 22(31.9) 47(68.1) 69(27.7) 3.20(1.47-7.00) 0.004 
>=5 27(60.0) 18(40.0) 45(18.1) 1  
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 The prevalence of HIV was 14.5% (36/249); malaria prevalence was higher among HIV negative children. 
In fact, HIV negative children were three time more likely to have malaria than HIV infected ones (OR = 3.1(1.15-
8.31), P = 0.015). There were 5 children infected both with malaria and HIV, thus a co-infection rate of 2% (5/249). 
According to Table 3, the number of false positives recorded for SD-RDT was 88 and that of false negatives 19. The 
sensitivity and specificity of SD-RDT were respectively 75% (57/76) and 49.1% (85/173). The Positive Predictive 
Value (PPV) and Negative Predictive Value (NPV) were respectively 39.3% (57/145) and 81.7% (85/104). 
 
Table 3: Performance of the SD Bioline-TDR compared to microscopy 
 
 
SD Bioline-TDR 
Microscopy 
 Negative positive Total 
Negative 85 TN 19 FN 104 
Positive 88 FP 57 TP 145 
Total 173 76 249 
TN: True Negative; FP: False Positive; FN: False Negative; TP: True positive 
 
The correlation between the parasitaemia and the result of the RDT test was also analyzed (Table 4).  
 
Table 4:  SD Bioline-TDR results according parasitemia (number of trophozoites/µl) 
 Negative n (%) 
173(69.5) 
Positive n (%) 
76(30.5) 
Total 
249 
≤50 1(50.0) 1(50.0) 2 (2.6) 
]50,100] 1(25.0) 3(75.0) 4(5.3) 
]100,500] 3(27.3) 8(72.7) 11(14.4) 
]500,1000] 0(0.0) 4(100.0) 4(5.3) 
]1000,5000] 2(9.1) 20(90.9) 22(28.9) 
>5000 12(36.4) 21(63.6) 33(43.4) 
 
 In particular, Figure 1 shows that the efficacy of the RDT increases with the level of parasitaemia and 
reaches a maximum of 100% with 500-1000 trophozoites/µl, after which it decreased to 63.6% when more than 5,000 
trophozoites/µl were present. 
 
 
 
Figure 1: Prevalence (%) of malaria using SD Bioline Malaria Ag P.f/Pan-TDR according to parasitemia level 
(number of trophozoites/µl). 
 
The ROC curve for SD-RDT with parasitaemia (Figure 2) shows a low area under the curve of 0.446 (95% CI 
= 0.29-0.60).  This means that because of the low sensitivity and specificity of the SD-RDT when compared with 
microscopy, the RDT is not very suitable for diagnosis alone.   
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Figure 2: ROC Curve for SD Bioline Malaria Ag P.f/Pan -TDR with parasitemia 
 
We compared the results obtained in our study with those of other authors. These results are summarized in Table 5. 
 
Table 5: Performance evaluation of SD bioline malaria Ag pf/pan RDT against Microscopy by various authors 
Authors Country Age range study 
population 
Se Sp Reference 
Ratsimbasoa et al Madagascar 0.5-63 92.9 98.9 AJTMH, 2008 
Ogouyemi et al Benin 0.5-70 96.3 95.6 Bulletin de la société 
pathologie exotique, 2013 
Djalle et al Central African 
Republic 
All age 88.2 / BMC infect Dis, 2014 
Akotet et al Gabon 1-8 96.8 89.3 Malar chemotherapy control 
and elimination, 2014 
Tseroni et al Greece 3-67 97.4 99.4 PlosOne, 2015 
Sakthivel et al India 1-60 78.3 81.8 Am J Epidemiol Inf Dis, 2015 
Tadesse et al Ethiopia 1-80 99.5 98.0 Rev Inst Med Trop Sao Paulo, 
2016 
Ali et al Cameroon 1-16 98.0 65.0 Malar J, 2016 
Se: Sensitivity, Sp: Specificity 
 
Discussion 
 
The sensitivity of the SD BIOLINE Malariae Antigen P.f / Pan was 75% in this study, which is less than that 
recommended by WHO for a RDT (> 95%).The sensitivity of this RDT found in several studies varies, as shown in 
Table 5, from 88.2 to 99.5%.These studies were done in several countries, endemic and non endemic for malaria, on 
several geographic populations of different age range and with various parasitaemia levels and Plasmodium species. 
The difference in sensitivity obtained in these studies could be explained by the genetic polymorphism in HRP2 (Baker 
et al., 2005; Kilian et al., 1997; Amos 2005). Anti-HRP2 antibodies produced in some patients leading to the 
neutralization of HRP2 produced by plasmodia could also be the reason for the poor sensitivity (Biswas et al., 2005; 
Lee at al., 2006). Low parasitaemia levels could also explain the various sensitivities of this RDT, but they do not seem 
to be the case in our study population, as 75% of the patients positive for RDT had a parasitic load > 501/μL. In a 
country like Cameroon with regular exposure to Plasmodium one observes tolerance (clinically asymptomatic); 
requiring a higher rate of blood parasites for positive RDT (Munier et al., 2009).  
Furthermore, deletions or mutations in the HRP 2 gene may reduce the sensitivity of these RDTs (Baker et al., 
2005; Kumar et al., 2013; Wurtz et al., 2013; Maltha et al., 2012; Koita et al., 2012; Houze et al., 2011).  
The specificity of the SD BIOLINE Malariae Antigen Pf/pan obtained in this study was 49.1%. Other studies have 
shown a specificity ranging from 65-99.4% (Table 5).  
 The relatively high rate of false positives could be due to several factors such as the presence of jaundice in 
patients (Grobusch et al., 1999); rheumatoid antigens (Bartoloni et al., 1998; Iqbal et al., 2000) or other antibodies 
(WHO, 2011; Gillet et al., 2013); to the persistence of HRP2 antigen in the blood several days after clearance of  
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Plasmodium (Mayxay et al., 2001; Wonsrichanalai et al., 2007; Rakotonirina et al., 2008; WHO, 2008 b) or by self-
medication taken before deciding to consult when the symptoms persist. All these possibilities could explain the high 
rate of false positive obtained with SD-RDT in all age groups. 
 The Negative Predictive Value (NPV) which is the probability that a patient does not have malaria when the 
SD-RDT is negative, was 81.6% (Table 3) This indicates that out of 100 patients testing negative with using the SD-
RDT, about 82 were actually free from malaria (negative microscopy) leading to 18 patients being wrongly prescribed 
anti-malarial drugs. If this can be avoided then it could contribute to reducing the phenomenon of resistance in areas of 
high transmission (Molyneux et al., 1999; Hastings et al., 2000), responsible for treatment failure.   
 The positive predictive value (PPV), measures the probability that a patient tested positive by SD-RDT is 
actually infected with Plasmodium. In this study PPV was 39.3%, lower than 86.7% obtained in Benin (Ogouyèmi-
Hounto et al., 2013). This means that, 60 times out of 100, a person whose SD-RDT was positive had no malaria (when 
tested by microscopy). This will lead to over-prescription, development of resistance and money wasted (Grawley et 
al., 2010). Hence, it is important to use two diagnostic tests for better decision making, just like in other cases such as 
HIV testing that combines 2-3 tests, before deciding that drug treatment is appropriate. 
The predictive values (PPV and NPV) always depend on the prevalence of the disease in the area of study. Indeed, for a 
test with given sensitivity and specificity, predictive values (PPV and NPV) differ with disease prevalence in the study 
population (Mac Morrow, 2008).  
 Ali et al, (2016) evaluated the accuracy of 22 RDT in Cameroon on children, among which SD Bioline 
Malaria Antigen P.f/Pan was included. These 22 tests have sensitivity ranging from 63% to 98%; and a specificity 
ranging from 48% to 92%. We thus suggest that as in HIV diagnosis, an algorithm should be developed to use two 
tests, one with higher sensitivity and the second with higher specificity. 
We have observed the prozone effect with SD-RDT as shown in Figure 1 and by other authors (Gillet et al., 2009b). 
Maximum sensitivity was at a parasitaemia level between 500-1000 trophozoites/µl. This presents a major limitation of 
this RDT as parasitaemias is usually high in children. 
Although HIV prevalence in our study population was 14.5%, malaria-HIV co-infection was 2%. 
Bed net usage decreased linearly as the age group increased (p-Cochran-Armitage test of trend = 0.000); starting from 
74.8% for less than 2 years, 68.1% for those aged 2-5 years and 40% for 5 years and above (Table 2). Children under 2 
years and those aged 2-5 years were respectively four times (OR = 4.46(2.19-9.08), p = 0.00)) and three times (OR = 
3.20.(1.47-7.00), p = 0.004)) more likely to use a bed net than those who were 5 years and older. As the child grows, 
the usage of bed nets becomes problematic, as they could easily get out of the bed net and be exposed to malaria.  
The prevalence of malaria was significantly higher in girls than boys with p value of 0.015. No other study on pediatric 
malaria has shown gender susceptibility (EDS-MICS, 2011). It has been shown for other infections that males are in 
general more susceptible to infectious diseases than females, and this has been mostly ascribed to the 
immunosuppressive activity of testosterone. But in this study, contradictory results were obtained. No other studies 
have linked the female gender to the susceptibility of malaria. This will be investigated further.  
 
Conclusion 
 
RDT tests are a good tool to overcome drawbacks presented by conventional diagnostic tool. But these tools 
should be evaluated and validated for the specific context in which they are to be used. In case this is not possible, the 
use of RDT for malaria should be associated with clinical symptoms. We suggest that an algorithm should be 
developed for malaria as is the case for RDT for HIV. We also suggest that usage of bed net be adapted according to 
the age of children to ensure good usage. 
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